The ascension of Sildenafil initially ignited significant growth in the pharmaceutical sector, creating a image of easy returns. However, funding in companies primarily reliant on flagship drugs like the erectile https://georgiafaga517042.anchor-blog.com/21510525/the-blue-pill-and-pharma-a-speculative-bet